Welcome Guest
Home > Clinical Lymphoma & Myeloma > Volume 3 |  Issue 2 > Article Abstract

Abstract
Back to TOC
Add to Favorites
X
  • Volume 3
  •  Issue 2
    • Publication Date: September 2002


Mantle Cell Lymphoma: New Treatments Targeted to the Biology


Francesco Bertoni, Michele Ghielmini, Franco Cavalli, Finbarr E. Cotter, Emanuele Zucca

Mantle cell lymphoma (MCL) represents a distinct lymphoma subtype. The prognosis of patients with MCL is the poorest among lymphoma patients and the response to conventional treatments is inadequate. New approaches targeted to the biology of MCL and the genetics underlying the disease are being studied. Monoclonal antibodies directed at molecules expressed on MCL cells are already used in the clinical setting. This article reviews the literature on these and other new possible treatment modalities.

Key words: Monoclonal antibodies, Rituximab, Tositumomab, Ibritumomab, Apoptosis, CD20, Proteasome inhibitors


  1. https://www.ceteresopolitano.org/
  2. https://www.crossingstoronto.com/
  3. https://www.jediism.org/
  4. https://www.badenumc.org/
  5. https://www.johnsevierchapter.org/
  6. https://www.trinitychapelmn.org/
  7. https://www.photogearnews.com/
  8. https://www.alz-nova.org/
  9. https://www.cigjournals.com/
  10. https://summa-edu.com/
  11. https://cpawilmingtonnc.org/
  12. https://bimometals.com/
  13. https://sosenvironmental.com/
  14. https://thefriary.org/
  15. https://post5theatre.org/
  1. Pengeluaran SDY